Maze Therapeutics

Photo of Wall Street street sign with american flags in the background
Biotech

Metsera, Maze go public with IPOs of $275M, $113M

Obesity biotech Metsera and metabolic-focused Maze have met their IPO expectations as the two companies prepare to join the Nasdaq this morning.
James Waldron Jan 31, 2025 7:40am
Business person contemplating how to navigate a maze made of money

Maze rolls out map to $131M IPO

Jan 27, 2025 9:45am
Polaris shining brightly in the night sky

Maze charts path through clinical development with planned IPO

Jan 7, 2025 5:40pm
Business person contemplating how to navigate a maze made of money

Maze finds its way to $115M series D

Dec 3, 2024 12:42pm
Graphic of two hands shaking under a red and purple light

After FTC stalled Sanofi deal, Shionogi bags Maze's Pompe drug

May 10, 2024 5:02am
Graphic image of the words try again on a purple background with some pixelated art below

Sanofi CEO does not rule out future Pompe BD despite FTC moves

Jan 10, 2024 3:37pm